Viewing nowGlupide Tablets (Glibenclamide)
Glimepiride 2mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 200400801 · Notified 2004.09.03 · Insurance code 640900080
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with diet and exercise therapy to assist in blood sugar control for patients with type 2 diabetes. It can be administered alone, and if blood sugar control is inadequate, it may be combined with oral hypoglycemics or insulin. For example, this medication can be used with metformin when sulfonylureas or metformin monotherapy is not effective. Such treatment methods help improve blood sugar management.
Adjust the dose individually for each patient. Swallow whole without chewing, with at least 1/2 cup of water. Take this medicine orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control with an increase to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider using this medicine in combination with insulin or another oral antidiabetic agent. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, a dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2 week intervals. The potency and duration of action of the previously administered medicine should be taken into account. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly corrected by immediately consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. With combination therapy of this medicine and metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Patients who are allergic to this medication or its components, or to sulfonylureas should also not use this medication. There is no experience using this medication in patients with severely impaired liver or kidney function, thus switching to insulin therapy is recommended. It should not be used in pregnant or potentially pregnant women, or breastfeeding women. Patients with severe infections, or those following surgery or severe trauma may require insulin therapy. Patients with gastrointestinal disturbances such as diarrhea or vomiting should be cautious, as these may lead to malabsorption and risk of hypoglycemia. During the first week of taking this medication, there is a high risk of hypoglycemia, so blood sugar should be closely monitored. Special attention is needed for the elderly, patients with poor nutritional status or irregular eating habits, those with mismatched exercise and food intake, changes in meal patterns, frequent alcohol consumption, those with weakened kidney or liver function, and those who overdose on this medication. This medication can cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, decreased concentration, confusion, dizziness, drowsiness, and decreased consciousness. Hypoglycemia is typically quickly alleviated by consuming sugary food or drinks. Rarely, visual disturbances, gastrointestinal issues, liver function abnormalities, blood disorders, and allergic reactions may occur, and if any abnormal symptoms arise, the patient should inform their doctor or pharmacist immediately. When taking this medication, regular meals, exercise, and weight management are crucial, and blood sugar control should be consistently monitored. If hypoglycemia occurs, sugar should be taken immediately, and the symptoms and risks of hypoglycemia should be clearly explained to the patient and their family to prepare for emergency situations. In situations of stress, surgery, or infections that make blood sugar control difficult, transitioning to insulin therapy may be considered. Pregnant or breastfeeding women should not use this medication, and women who plan to become pregnant must consult their doctor. Elderly patients may have reduced kidney function, so dosing should be adjusted cautiously. Overdosing on this medication can lead to severe hypoglycemia, so immediate medical treatment is necessary, and blood sugar should be monitored closely for 24 to 48 hours. The safety and efficacy of this medication have not been established in children, so it should not be used in children. When storing this medication, keep it out of the reach of children, and store it in the original container. There may be interactions when taken with other medications, so all medications the patient is currently taking should be disclosed to the doctor or pharmacist.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a sealed container. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's efficacy and safety for a long time.
Green rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Ilhwa Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.